Korsana Biosciences, Inc. (KRSA)
32.83
-2.16
(-6.17%)
USD |
NASDAQ |
Sep 21, 16:00
33.09
+0.26
(+0.79%)
After-Hours: 20:00
Korsana Biosciences Total Assets (Quarterly) : 6.93M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.93M |
| March 31, 2026 | 8.505M |
| December 31, 2025 | 9.985M |
| September 30, 2025 | 10.42M |
| June 30, 2025 | 9.37M |
| March 31, 2025 | 9.847M |
| December 31, 2024 | 9.575M |
| September 30, 2024 | 8.898M |
| June 30, 2024 | 10.06M |
| March 31, 2024 | 11.36M |
| December 31, 2023 | 13.37M |
| September 30, 2023 | 15.21M |
| June 30, 2023 | 10.10M |
| March 31, 2023 | 11.46M |
| December 31, 2022 | 18.08M |
| September 30, 2022 | 25.05M |
| June 30, 2022 | 35.21M |
| March 31, 2022 | 46.52M |
| Date | Value |
|---|---|
| December 31, 2021 | 59.33M |
| September 30, 2021 | 67.74M |
| June 30, 2021 | 75.73M |
| March 31, 2021 | 99.97M |
| December 31, 2020 | 115.38M |
| September 30, 2020 | 131.40M |
| June 30, 2020 | 128.04M |
| March 31, 2020 | 140.03M |
| December 31, 2019 | 186.48M |
| September 30, 2019 | 209.70M |
| June 30, 2019 | 235.50M |
| March 31, 2019 | 9.773M |
| December 31, 2018 | 7.401M |
| September 30, 2018 | 6.756M |
| June 30, 2018 | 5.724M |
| March 31, 2018 | |
| December 31, 2017 | 5.47M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Climb Bio, Inc. | 246.29M |
| Q32 Bio, Inc. | 115.87M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.843M |
| Shareholders Equity (Quarterly) | 5.087M |
| Current Ratio | 0.8215 |